Arbor Pharma gains FDA nod for 1st nimodipine oral solution
This article was originally published in Scrip
Executive Summary
The FDA on 14 May revealed it had approved Atlanta-based Arbor Pharmaceuticals' Nymalize, the first nimodipine oral solution to treat patients experiencing symptoms resulting from subarachnoid hemorrhage – serious, life threatening bleeding that occurs in the subarachnoid space, which is the area between the brain and the thin tissues that cover the brain.